Enhancing the QUAlity and Transparency Of health Research
Use your browser's Back button to return to your search results
|Reporting guideline provided for?
(i.e. exactly what the authors state in the paper)
|Reporting intervention description across studies assessing the impact of clinical pharmacy activities.|
|Full bibliographic reference||Rotta I, Salgado TM, Felix DC, Souza TT, Correr CJ, Fernandez-Llimos F. Ensuring consistent reporting of clinical pharmacy services to enhance reproducibility in practice: an improved version of DEPICT. J Eval Clin Pract. 2015;21(4):584-590.|
|Reporting guideline acronym||DEPICT 2|
|Study design||Clinical trials, Experimental studies|
|Clinical area||Pharmaceutical medicine|
|Applies to the whole report or to individual sections of the report?||Intervention (exposure)|
|Previous versions of this guideline / Guideline history||An earlier version of this reporting guideline was published in 2013:
Correr CJ, Melchiors AC, de Souza TT, Rotta I, Salgado TM, Fernandez-Llimos F. A tool to characterize the components of pharmacist interventions in clinical pharmacy services: the DEPICT project. Ann Pharmacother. 2013;47(7-8):946-952. PMID: 23757389
|Record last updated on||November 26, 2021|
Some reporting guidelines are also available in languages other than English. Find out more in our Translations section.